MicroRNA-200c Increases Radiosensitivity of Human Cancer Cells with Activated EGFR-associated Signaling by 구태률
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Introduction: A member of the microRNA-200 family, microRNA-200c (miR-
200c), recently was found to have tumor-suppressive properties by inhibiting the 
epithelial-mesenchymal transition (EMT) process in several cancers. miR-200c 
also interacts with various cellular signaling molecules and regulates many 
important signaling pathways. In the present study, we investigated the 
radiosensitizing effect of miR-200c and its mechanism of radiosensitization in a 
panel of human cancer cell lines. 
Methods: Malignant glioma (U251, T98G), breast cancer (MDA-MB-468), and 
lung carcinoma (A549) cell lines were transfected with control pre-microRNA, 
pre-miR-200c, or anti-miR-200c. Then, RT-PCR, clonogenic assays, 
immunoblotting, and immunocytochemistry were performed. To predict the 
potential targets of miR-200c, microRNA databases were used for bioinformatics 
analysis. 
Results: Bioinformatics analysis predicted that miR-200c may be associated with 
EGFR, AKT2, MAPK1, VEGFA, and HIF1AN. Ectopic overexpression of miR-
200c downregulated p-EGFR, p-PI3K, p-AKT, and p-ERK and increased the 
radiosensitivity of U251, T98G, A549, and MDA-MB-468 cells. In contrast, miR-
200c inhibition upregulated p-EGFR, p-PI3K, p-AKT, and p-ERK, and decreased 
radiation-induced cell killing. miR-200c led to persistent γH2AX focus formation 
and downregulated pDNA-PKc expression. Autophagy and apoptosis were major 
modes of cell death. We also confirmed that miR-200c downregulated the 
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expression of VEGF, HIF-1α, and MMP2 in U251 and A549 cells. In these cells, 
overexpressing miR-200c inhibited invasion, migration, and vascular tube 
formation. These phenotypic changes were associated with E-cadherin and EphA2 
downregulation and N-cadherin upregulation. miR-200c showed no observable 
cytotoxic effect on normal human fibroblasts and normal human astrocytes. 
Conclusions: miR-200c increased the cytotoxic effect of radiotherapy in a panel of 
human cancers with activated EGFR-associated signaling. The effects of miR-200c 
on the associated signaling molecules were indirectly confirmed with their 
phosphorylation levels. miR-200c also mitigated EMT-related processes. Taken 
together, our data suggest that miR-200c is an attractive target for improving the 
efficacy of radiotherapy via a unique modulation of the complex regulatory 
network controlling cancer pro-survival signaling and EMT. 
 
* This work is published in Oncotarget (Koo T, Cho BJ, Kim DH, Park JM, Choi 
EJ, Kim HH et al. Oncotarget. 2017 Jul 3;8(39):65457-65468). 
------------------------------------- 
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MicroRNAs (miRNAs) are important regulators of cell signaling pathways 
crucial for the growth of human cancer cells [1]. Cancer-associated miRNAs are 
located downstream of major oncogenes and tumor suppressor genes that act as 
transcription factors [2]. Alterations in miRNAs can result in cancer genesis and 
progression. For example, levels of some miRNAs are decreased in human cancers 
[3]. Therefore, understanding the regulatory function of miRNAs during tumor 
progression will contribute to the development of targeted molecular therapies. 
A member of the miRNA-200 family, miRNA-200c (miR-200c), recently was 
found to have tumor-suppressive properties by inhibiting the epithelial-
mesenchymal transition (EMT) process in several cancers. In primary glioblastoma 
multiforme (GBM) tissues, miR-200c and E-cadherin were found to be 
downregulated when epidermal growth factor receptor (EGFR) was highly 
amplified [4]. EGFR wild-type non-small cell lung cancer (NSCLC) cell lines 
regained sensitivity to EGFR tyrosine kinase inhibitors when EMT was inhibited 
by miR-200c overexpression [5]. In NSCLC patients with EGFR wild-type, high 
level of miR-200c was associated with better survival compared with low level of 
miR-200c [5].  
miR-200c also interacts with various cellular signaling molecules and regulates 
many important signaling pathways, such as STAT3, PI3K/Akt [6], and ERK [7]. 
Clinically, analysis of patient data using The Cancer Genome Atlas (TCGA) 
datasets showed that decreased miR-200 family expression was associated with 
poor overall survival in ovarian, renal, lung, and basal-like breast cancers [8].  
A potential correlation between miR-200c and radioresistant was explored 
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particularly in breast cancer cell lines. When relative levels of miR-200c 
expression were compared between basal phenotype breast cancer cells and 
luminal phenotype breast cancer cells, radioresistant basal cancer cells had lower 
expression level of miR-200c [9, 10]. However, at this time, it is not clear whether 
miR-200c has the radiosensitizing effect in human cancer cells with activated 
EGFR-associated signaling. 
In the present study, we investigated the radiosensitizing effect of miR-200c and 
the mechanism of radiosensitization in a panel of human cancer cell lines with 
activated EGFR-associated signaling. 
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MATERIALS AND METHODS 
Cell culture 
GBM (U251 and T98G) cells, NSCLC (A549) cells, breast cancer (MDA-MB-
468) cells, normal human astrocytes, and normal human fibroblasts were obtained 
from the American Type Culture Collection (ATCC, Manassas, VA, USA). All 
ATCC cell lines were authenticated by the company’s routine Cell Biology 
Program and were used within 6 months of receipt for this study. Cells were 
maintained and cultured according to standard techniques at 37°C in 5% (v/v) CO2 
using the culture medium recommended by the supplier. 
 
miRNA transfection 
Cells were transfected with pre-miR-200c (mature miR-200c sequence: 5-CGU 
CUU ACC CAG CAG UGU UUG GGU GCG GUUGGG AGU CUC UAA UAC 
UGC CGG GUA AUG AUG GA-3) or control pre-miRNA using siPORTNeoFX 




To deliver anti-miR-200c (Panagene Inc., Daejeon, South Korea; Cat No.PI-
1251; anti-miR-200c sequence: RRRQRRKKR-OO TTACCCGGCAGTATT) in 
the absence of a transfection reagent, anti-miR-200c was mixed with Opti-MEM 
(Invitrogen, Grand Island, NY, USA), incubated for 15 minutes at room 




Quantitative real-time polymerase chain reaction 
RT-PCR was performed using a Taqman miRNA reverse transcription kit and 
the Fast Real-Time PCR System (Applied Biosystems, Carlsbad, CA, USA). The 
fold-change of hsa-miR-200c miRNA levels was calculated and normalized to a 
hsa-mir-423 loading control. 
 
Clonogenic assay 
For the clonogenic assays, identical numbers of cells were plated across the 
different treatment groups for each radiation dose as previously reported [11]. Cells 
were seeded into each well of six-well culture plates and transfected with miRNA 
for 18 hours. After miRNA transfection, cells were irradiated with a 4-MV X-ray 
from a linear accelerator (Clinac 4/100, Varian Medical Systems, Palo Alto, CA, 
USA) at a dose rate of 2.46 Gy/minute and incubated for colony formation for 14 
to 21 days. Colonies were fixed with methanol and stained with 0.5% crystal violet; 
the number of colonies containing at least 50 cells was determined and the 
surviving fraction was calculated. Radiation-survival data were fitted to a linear-
quadratic model using Kaleidagraph version 3.51 (Synergy Software, Reading, PA, 
USA). The SER was defined as the ratio of the isoeffective dose at a surviving 
fraction (SF) of 0.5 and 0.05 in the overexpression of control miRNA to the 





Similar to methods used in a previous study [12], several miRNA target 




(http://mirdb.org/miRDB/index.html), picTar (http://pictar.mdc-berlin.de/), PITA 
(http://genie.weizmann.ac.il/pubs/mir07/mir07_data.html), RNA22 
(http://cm.jefferson.edu/rna22v1.0/), RNAhybrid (http://bibiserv.techfak.uni-
bielefeld.de/rnahybrid/), and TargetScan (http://www.targetscan.org/). When a 
putative gene was predicted in four or more of the databases, we validated whether 
the gene was reported to be associated with radiosensitivity using the Gene 
(http://www.ncbi.nlm.nih.gov/gene/) and KEGG PATHWAY Databases 
(http://www.genome.jp/kegg/pathway.html). 
 
Western blot analysis 
Cells were washed and suspended in lysis buffer (Cell Signaling Technology, 
Danvers, MA, USA). Proteins were solubilized by sonication and equal amounts of 
protein were separated by SDS-PAGE then electroblotted onto polyvinylidene 
difluoride membranes (Millipore Corp., Bedford, MA, USA). Membranes were 
blocked in PBS containing 0.1% Tween-20 and 5% powdered milk, and probed 
with the appropriate primary antibody. Primary antibodies against phosphorylated 
EGFR (p-EGFR; Tyr1068), p-PI3K 110а (Cell Signaling Technology), DNA-
protein kinases (PKs) (Thr2609), HIF-1α, MMP2 (Abcam, Cambridge, MA, USA), 
p-AKT (Ser473), p-ERK1/2, VEGF, and β-actin (Santa Cruz Biotechnology, Santa 
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Cruz, CA, USA) were used at a dilution of 1:1000. The expression level of each 
protein was analyzed using ImageJ (Rasband, W.S., ImageJ, U. S. National 
Institutes of Health, Bethesda, MD, USA, http://imagej.nih.gov/ij/, 1997-2016) 
program (Supplemental data 4).  
 
Immunocytochemistry 
Cells were grown and treated on chamber slides. At specified times after 
treatment with each inhibitor, cover slips were rinsed and cells were fixed in 4% 
paraformaldehyde then permeabilized in methanol for 20 minutes. Cells were 
subsequently washed and blocked in PBS containing 2% bovine serum albumin for 
1 hour. Primary antibodies against γH2AX (Cell Signaling Technology), VEGF 
(Santa Cruz Biotechnology), EphA2 (Santa Cruz Biotechnology), LC3 (Cell 
Signaling Technology, Inc.), or Caspase-3 (Santa Cruz Biotechnology) were 
applied to the cells and incubated overnight. A secondary FITC anti-rabbit 
antibody (Molecular Probes, Eugene, OR, USA) was applied and incubated for 1 
hour. DAPI nuclear counterstain was applied at 1 μg/mL for 5 minutes. Slides were 
examined on an Axio Scope.A1 Imager fluorescence microscope (Carl Zeiss, 
Gottingen, Germany. Images were captured using an AxioCam MRc5 and 
acquisition software AxioVision v.4.4 (Carl Zeiss). 
 
Annexin V/propidium iodide double-staining 
Apoptosis was examined using Annexin V/propidium iodide (PI) double staining. 
Cells were seeded onto an 8-well chamber slide, doubled stained with Annexin V 
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and propidium iodide according to the manufacturer's instructions, and then 
subjected to the analyzer (BD, Franklin Lakes, NJ, USA).  
 
Cell labeling with LysoTracker 
To detect autophagy, cells were incubated with 1 µM LysoTracker (Molecular 
Probes, Eugene, OR, USA) for 10 seconds during irradiation according to the 
manufacturer’s instructions. After incubation, cells were washed with PBS and 
analyzed by fluorescence microscopy. 
 
β-galactosidase staining for senescence 
Cellular senescence was evaluated using a β-Galactosidase Staining Kit (Cell 
Signaling Technology). Medium was removed and cells were washed with PBS. 
The β-galactosidase staining solution (1 mL) was added to each 35 mm well and 
cells were incubated at 37C overnight according to the manufacturer’s instructions. 
 
Wound healing assay 
Cells (5  106 cells/well) at 48 hours post-transfection were counted and seeded 
into six-well tissue culture plates (SonicSeal Slide; Nalge Nunc, Rochester, NY, 
USA) and grown until 90% confluence. A vertical or horizontal wound was created 
using a 1000 L pipette tip. The wounded cells were rinsed three times with 1 
PBS to remove all cellular debris. Serum-free medium was added and the cells 
were allowed to migrate for 48 hours. Images were microscopically captured at 
designated times to assess wound closure. The inhibition effectiveness was 




Modified Boyden chamber assay 
Cell invasion was measured using a Transwell system (Corning, Rochester, NY, 
USA), which allows cells to migrate through 8 m pores in polycarbonate 
membranes. The membranes were coated with a 10 g/well gelatin solution in 
starvation medium and subsequently dried. Inserts containing cells were placed 
into 24-well plates (Corning) in starvation medium. Cells were trypsinized, washed, 
and resuspended (5  106 cells/mL) in starvation medium. Cells (104) were added 
to the upper chamber. The lower chamber was filled with 500 L medium. After 
24 hours, the surface of the upper membrane was swabbed with a cotton-tipped 
applicator to remove remaining cells. Inserts were fixed in methanol for 10 minutes 
and stained with 1% crystal violet for 2 hours. Invasion rate was estimated 
microscopically from the number of cells that migrated into the lower chamber. 
 
Vasculogenic mimicry formation assay 
Vasculogenic mimicry formation assay was performed using a commercialized 
Matrigel assay kit (BD Biosciences). ECM Matrigel (200 μL) was added to 48-well 
tissue culture plates and then incubated at 37°C for 2 hours. Cells were transfected 
with pre-miR-200c or control 1 day before seeding onto coated plates. After 
growth for 24 hours on the plate, vasculogenic mimicry formation was assessed 





Statistical analysis was performed by Student’s t-test using IBM SPSS ver. 20 






Ectopic overexpression of miR-200c increases the radiosensitivity of human 
cancer cells with activated EGFR signaling 
Ectopic overexpression of miR-200c increased the radiosensitivity of GBM 
(U251 and T98G), NSCLC (A549), and breast cancer (MDA-MB-468) cells. The 
sensitizer enhancement ratios (SER), calculated as the isoeffective dose to obtain 
50% survival (SER0.5), were 1.24, 1.20, 1.05, and 1.12 for U251, T98G, A549, and 
MDA-MB-478 cells, respectively. In contrast, radiation-induced cell killing was 
decreased by anti-miR-200c (Figure 1A, 1B, 1C, and 1D).  
 
miR-200c overexpression induces prolongation of γH2AX focus formation and 
down-regulates p-DNA-PKcs 
Having demonstrated that miR-200c increased radiosensitivity in cancer cells 
with activated EGFR signaling, we next planned to confirm the mechanism of 
radiosensitization. Overexpression of miR-200c caused a marked prolongation of 
γH2AX focus formation 4 hours after irradiation with 6 Gy. This was associated 
with a discernible downregulation of p-DNA-PKcs, which are involved in the non-
homologous end joining repair process following DNA double-strand breakage 









Surviving fraction 0.5 0.05 
Sensitizer enhancement ratio 1.24 1.25 
Surviving fraction 0.5 0.05 






Surviving fraction 0.5 0.05 
Sensitizer enhancement ratio 1.05 1.11 
Surviving fraction 0.5 0.05 






Surviving fraction 0.5 0.05 
Sensitizer enhancement ratio 1.20 1.18 
Surviving fraction 0.5 0.05 







Surviving fraction 0.5 0.05 
Sensitizer enhancement ratio 1.12 1.10 
Surviving fraction 0.5 0.05 
Sensitizer enhancement ratio 0.94 0.88 
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Figure 1. Effects of miR-200c on radiation response and EGFR-associated 
signaling.  
Ectopic overexpression of miR-200c inhibited expression of p-EGFR and 
downstream signaling molecules PI3K 110а, p-AKT, and p-ERK, and increased 
the radiosensitivity of U251 (A), T98G (B), A549 (C), and MDA-MB-468 (D) 
cells. In contrast, miR-200c inhibition upregulated the expression of the above 
proteins and decreased radiation-induced cell killing. Points on the survival curves 
represent surviving fractions calculated from cells treated in triplicate. Each 






Figure 2. Overexpression of miR-200c led to prolonged γH2AX focus 
formation and p-DNA-PKcs downregulation.  
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Overexpression of miR-200c caused a marked prolongation of γH2AX focus 
formation at 4 hours after irradiation with 6 Gy (right panels) and was associated 
with discernible downregulation of p-DNA-PKcs (left panels) in U251 (A), T98G 




Mode of cell death: apoptosis, autophagy, and senescence 
The effect of miR-200c on apoptosis was confirmed using Annexin V/ PI double 
staining [13]. Treatment of U251 and A549 cells with anti-miR-200c before 
irradiation significantly reduced apoptotic or necrotic cell death compared to 
expression of miR-200c (Figure 3A). We also examined the expression of caspase-
3, a key apoptosis-triggering factor, and confirmed that caspase-3 was upregulated 
when U251 and A549 cells were treated with both miR-200c and radiotherapy 
(Figure 3A). These results showed that miR-200c and radiotherapy synergistically 
induced apoptotic cell death in human GBM and NSCLC cells. 
Cellular stressors such as irradiation can trigger senescence signaling cascades 
that may promote autophagic cell death [14]. We evaluated the influence of miR-
200c on the ability of U251 and A549 cells to form autophagosomes, which are 
associated with autophagy or autophagic cell death. Upon miR-200c 
overexpression, U251 and A549 cell lines showed a significantly higher degree of 
accumulation of acidic compartments, as demonstrated by labeling cells with 
LysoTracker and subsequent analysis by fluorescence microscopy. In both cell 
lines, treatment with miR-200c and irradiation (6 Gy) resulted in lysosomal 
localization of LysoTracker within 24 hours of treatment (Figure 3B). To elucidate 
the mechanism underlying autophagy in U251 and A549 cell lines, we investigated 
the effects of miR-200c and anti-miR-200c on the conversion of microtubule-
associated protein light chain (LC3), an autophagosome marker. Both cell lines 
were positive for the unconjugated (LC3-I) and the conjugated (LC3-II) forms as 
determined by western blotting. However, treatment with miR-200c upregulated 




Figure 3. Effects of miR-200c on apoptosis, autophagy, and senescence.  
(A) Annexin V/propidium iodide (PI) double staining was used to assess the degree 
of apoptosis or necrosis in cells with or without 6 Gy of radiation. Treatment with 
anti-miR-200c dramatically reduced apoptosis in U251 and A549 cells. Caspase-3 
expression also correlated with apoptosis. (B) Treatment with both miR-200c and 6 
Gy irradiation notably induced autophagy in U251 and A549 cell lines. On the 
other hand, anti-miR-200c treatment rendered both cell lines more resistant to 
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autophagic cell death. Expression of the autophagosome marker LC3 was 
upregulated after miR-200c treatment, whereas it was reduced after anti-miR-200c 
treatment. (C) The effect of miR-200c on cellular senescence was not significant 
compared to normal control cells or cells treated with anti-miR-200c as determined 




associated with the number of autophagosomes [15]. According to these results, 
miR-200c and radiation synergistically induced autophagic cell death in GBM and 
NSCLC cells.  
However, the effects of miR-200c on cellular senescence as determined by β-
galactosidase staining indicated no significant difference from normal controls or 
cells treated with anti-miR-200c (Figure 3C). 
 
Target prediction and confirmation for miR-200c 
Bioinformatics analysis predicted that EGFR had the high probability of being a 
miR-200c target (Table 1). Thus, the cell lines used in the current study should be 
valid tools to determine this because of their activated EGFR signaling status. 
Western blot analysis confirmed that miR-200c overexpression decreased the 
expression of p-EGFR (Figure 1). 
Regarding signaling pathways, we focused on pathways that were previously 
reported to be associated with radiosensitivity such as PI3K/Akt and ERK [12, 16]. 
These pathways are well known to decrease radiation-induced cell apoptosis and 
increase cell proliferation. Bioinformatics analysis also suggested PI3K, AKT, and 
ERK1/2 as putative targets of miR-200c. As presented in Figure 1, the ectopic 
overexpression of miR-200c led to attenuated formation of PI3K 110α, p-AKT, and 
p-ERK. 
Angiogenesis and EMT-associated genes such as VEGFA, HIF1AN, and CDH1, 
were predicted as target genes of miR-200c. We performed western blots and 




Table 1. Target gene prediction using miRNA target databases 
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Ectopic expression of miR-200c inhibits angiogenesis, invasion, and migration  
Overexpression of miR-200c led to discernible inhibition of vasculogenic 
mimicry and was associated with downregulation of VEGF, HIF-1α, and MMP2. 
The overexpression of VEGF in human cancer cell lines U251 and A549 was 
confirmed by immunocytochemistry using an anti-VEGF antibody. However, 
treating these cell lines with miR-200c resulted in significantly lower VEGF 
expression (Figure 4A and 4B). 
To explore the crucial role of miR200c in EMT through controlling cell 
migration and polarity, we evaluated invasion and migration in the panel of human 
cancer cells. Overexpressing miR-200c significantly inhibited the invasion 
potential of U251 and A549 cells (Figure 5A). miR-200c also significantly 
compromised migration in U251 and A549 cells as determined by wound healing 
assay, while a miR-200c inhibitor restored the migration potential (Figure 5B). As 
shown in Figure 5C, U251 and A549 cells treated with miR-200c exhibited 
downregulated E-cadherin and upregulated N-cadherin. Expression of EphA2 also 
was significantly reduced after treatment with miR-200c, whereas cells treated with 









Figure 4. Effects of miR-200c on vascular tube formation.  
Overexpression of miR-200c led to a discernible inhibition of vasculogenic 
mimicry and was associated with downregulation of VEGF, HIF-1α, and MMP2. 
VEGF antibody staining also confirmed the downregulation of VEGF in cell lines 










Figure 5. Effects of miR-200c on invasion and migration potential and E-
cadherin, N-cadherin, and EphA2 expression.  
(A) Overexpression of miR-200c significantly inhibited the invasion potential of 
U251 and A549 cells. (B) miR-200c significantly compromised the migration 
potential of U251 and A549 cells, which was restored by miR-200c inhibition. 
Overexpressing miR-200c increased E-cadherin expression while treatment with 
anti-miR-200c decreased E-cadherin expression. Anti-miR-200c also enhanced 
EphA2 expression whereas U251 and A549 cells incubated with anti-miR-200c 




Normal cell toxicity 
To evaluate the toxicity of miR-200c in normal cells, a clonogenic assay was 
performed. The ectopic expression of miR-200c resulted in no observable cytotoxic 








Figure 6. Testing toxicity of miR-200c in normal cells.  
Ectopic overexpression of miR-200c did not alter the radiosensitivity of normal 
human astrocytes (A) or normal human fibroblasts (B). Points on the survival 
curves represent mean surviving fractions calculated from the treated cells in 






miRNAs have complex interactions with mRNAs, but a few of their targets have 
been revealed by experiments. To overcome the limited experimental data, several 
miRNA target prediction algorithms have been developed. We used multiple target 
prediction algorithms to establish target gene candidates of miR-200c as previously 
reported [12], since the computational results often have inconsistencies [17]. 
Predicted targets were confirmed by western blotting. Our results suggested that 
miR-200c is an important modulator of the EGFR pro-survival cell signaling 
network implicated in the radiation response of human cancer cells. To the best of 
our knowledge, this is the first report to evaluate the regulatory role of miR-200c in 
response to radiation in GBM cells. 
Although we confirmed targets of miR-200c with indirect methods 
demonstrating the phosphorylation levels of the signaling molecules, several 
studies revealed that miR-200c directly targets KRAS, PI3K-Akt or ERK with 
luciferase assays [7, 18, 19]. In MDA-MB-231 cells co-transfected with miR-200c, 
the wild KRAS 3′-untranslated region (3′-UTR) had decreased luciferase 
expression, while the mutated KRAS 3′-UTR had no decrease. The 
phosphorylation levels of AKT and ERK were negatively regulated by miR-200c, 
then increased with re-expression of KRAS in 4T1 cells [7]. In MG-63 human 
osteosarcoma cells, miR-200c significantly suppressed luciferase activity in the 
wild AKT2 3′- UTR, but not in the mutated AKT2 3′-UTR [18]. 
Inhibiting the PI3K/Akt signaling complex increased radiosensitivity in 
EGFR-activated cells by suppressing pro-survival signaling and DNA damage 
repair [20]. In our previous reports [12, 16] , we observed that overexpressing 
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miRNAs was associated with downregulated EGFR-associated signaling and 
increased radiosensitivity of human cancer cells that have activated EGFR and/or 
co-activation of PI3K-Akt signaling. Overexpression of miRNAs led to impaired 
DNA damage repair, which was associated with downregulated p-ATM or p-DNA-
PK. Here we also report that overexpressing miR-200c resulted in findings 
indicating impaired DNA damage repair. We therefore speculated the same 
radiosensitization mechanism resulted from inhibiting the EGFR-associated 
signaling network. 
The additional regulatory roles of miR-200c in important cellular signaling 
pathways other than PI3K-Akt or ERK have been reported. In breast cancer cells, 
miR-200c suppressed ubiquilin-1 expression and enhanced radiation-induced 
autophagy [9]. Tank-binding kinase-1 (TBK1), also a reported target of miR-200c, 
inhibits radiation-induced apoptosis in breast cancer and NSCLC cells [10, 21]. 
Enhanced chemosensitivity by miR-200c was also reported to occur through the 
Akt [22, 23] and JNK2/c-Jun [24] signaling pathways. Notch signaling activation 
was also reported to be regulated by miR-200c in human cancer cell lines [25, 26]. 
Notch genes are responsible for the expression of transmembrane receptors 
involved in communication between cells that are in contact. The Notch signaling 
network has been associated with radioresistance, and has been suggested to be a 
novel therapeutic target for cancer treatment [27-29]. 
miRNAs also affect a particular set of pro-survival cellular signals that 
enhance EMT, conferring cells with the ability to achieve carcinogenesis and 
invasiveness. Recently, a correlation between EMT and radioresistance was 
reported. In a gene signature study using Gene Expression Omnibus (GEO; glioma 
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patients) and TCGA (GBM patients) datasets, samples with a radioresistant 
phenotype were enriched with EMT-related genes, while samples with a 
radiosensitive phenotype had decreased levels of EMT-related genes [30]. In vitro, 
EMT-like phenotype and E-cadherin loss induced by hypoxia contributed to 
radioresistance in breast cancer cells [31]. In head and neck cancer patients who 
had low levels of EMT-inhibiting miRNA expression pre-treatment, intrinsic 
radioresistance was confirmed [32].  
We observed a significant loss of E-cadherin expression upon miR-200c 
inhibition in GBM and NSCLC cell lines. One of the first steps in the invasion of 
malignant cells through a weakened epithelium is loss of E-cadherin expression [33] 
and overexpression of N-cadherin [34]. Loss of E-cadherin in epithelial cells 
results in the emergence of mesenchymal characteristics during EMT [35]. We also 
confirmed that miR-200c inhibited the invasion and migration potential of GBM 
and NSCLC cell lines with activated EGFR pathways. Adam et al. [36] observed 
that the expression of miR-200c reversed the EMT transition in bladder cancer 
through the EGFR signaling pathway. Several groups also reported that the 
sensitivity of cancer cells to EGFR-targeted therapy is associated with E-cadherin 
expression and other characteristics of typical “epithelial” tumor phenotypes [35, 
37-40]. These results demonstrated the critical regulatory role of miR-200c on 
EMT-related signaling pathways through one of the most important cell signaling 
pathways in cancer, EGFR signaling.  
miR-200c particularly suppresses the Zinc finger E-box-binding homeobox 1 
(ZEB1)/E-cadherin axis, an activator of EMT and a key promoter of metastasis 
[41]. Recent observations have strengthened the role of the ZEB1/miR-200c 
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regulatory loop during EMT; on the one hand, miR-200c regulates ZEB1 
expression; on the other hand, ZEB1 regulates miR-200c transcription [41, 42]. 
Tissue microarrays of 30 primary GBM samples reported an inverse correlation 
between miRNA-200c and ZEB1. GBM samples with high EGFR amplification 
exhibit ZEB1 upregulation and miR-200c downregulation [4]. In NSCLC cells 
(A549), inhibiting TBK1 attenuated radiation-induced EMT by activating glycogen 
synthase kinase-3β and decreasing ZEB1 expression [21]. EMT in cancer cells can 
lead to chemoresistance and radioresistance. In a study using doxorubicin-resistant 
MCF-7 breast cancer cells, loss of miRNA-200c was associated with decreased E-
cadherin and PTEN expression, and increased ZEB1 and p-Akt expression, which 
ultimately caused chemoresistance [22].  
We further confirmed another post-transcriptional role of miR-200c: inhibiting 
vascular formation. It is well known that HIF-1 increases vascular formation, cell 
survival, invasion, and radioresistance in cancer cells [43, 44]. MMP-2 and VEGF, 
as transcriptional targets of HIF-1, play an important role in angiogenesis of 
NSCLC and GBM via the PI3K/AKT signaling pathway [45, 46]. In NSCLC cells 
(A549), miR-200c was reported to have a radiosensitizing effect by targeting the 
VEGF-VEGFR2 pathway. [47]. Therefore, miR-200c could be a viable target to 
increase radiation-induced cell killing of human tumor cells. 
In this study, we found that miR-200c significantly suppressed EphA2 
expression in GBM and NSCLC cells. To our knowledge, this is the first study to 
report a correlation between miR-200c and EphA2 in GBM and NSCLC cells. 
EphA2 is a member of the Eph receptor family, the largest family of tyrosine 
kinase receptors, which controls cell growth, migration, and differentiation. In 
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GBM, EphA2 was overexpressed [48] and this was related with invasiveness and 
poor prognosis [49]. Similarly, in NSCLC, EphA2 overexpression was correlated 
with EGFR activation, K-Ras mutation, and poor prognosis [50]. Eph has been 
proposed as an effective therapeutic target for GBM and NSCLC due to the cross-
talk that occurs between EphA2 and EGFR signaling [51-53].  
In conclusion, we confirmed that miR-200c significantly enhanced the cytotoxic 
effect of radiotherapy in a panel of human cancer cell lines. This radiosensitizing 
effect was associated with attenuated EGFR-associated pro-survival signaling and 
impaired DNA damage repair. We indirectly confirmed the decreased 
phosphrylation levels of the signaling molecules: p-EGFR, p-PI3K, p-AKT, and p-
ERK. miR-200c also mitigated EMT-related processes such as vascular formation, 
invasion, and migration. Taken together, our data suggest that miR-200c is an 
attractive target for improving the efficacy of radiotherapy via its unique 
modulation of the complex regulatory network controlling cancer pro-survival 
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서론: MicroRNA-200c (mir-200c)는 다양한 세포간 신호전달물질과 상호작
용하거나 주요 신호전달경로를 조절하는 기능을 가진다. 또한 miR-200c
는 epithelial-mesenchymal transition (EMT) 과정을 저해하여 악성 종양의 
진행을 억제한다고 알려져 있다. 본 연구는 EGFR 신호전달체계가 활성
화된 인간암세포에서 miR-200c 가 방사선민감성을 향상시킬 수 있는지 
확인하고, 관련 기전을 규명하고자 하였다.  
방법: 교모세포종 (U251, T98G), 유방암 (MDA-MB-468), 비소세포성폐암 
(A549) 세포주에 control pre-microRNA, pre-miR-200c, anti-miR-200c를 주입
하였다. 방사선민감성 향상을 확인하기 위하여 세포집락검사 (clonogenic 
assay)를 시행하였다. MicroRNA 데이터베이스를 활용하여 miR-200c의 표
적을 추정한 후 면역블롯검사 (immunoblotting)를 시행하여 단백질의 차
이를 확인하였다. 방사선조사 후 DNA double-strand breakage 를 비교하기 
위하여 면역세포화학검사 (immunocytochemistry)를 시행하여 γH2AX 형
성을 확인하였다. 세포사의 방식이 세포고사 (apoptosis)임을 확인하기 위
한 Annexin V/Propidium Iodide double staining, 자가포식 (autophagy)임을 확
인하기 위한 LysoTracker cell labeling, 세포노화 (senescence)임을 확인하기 
위한 β-galactosidase staining을 시행하였다. 또한, miR-200c가 EMT 관련 
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기전을 억제하는지 확인하기 위하여 vasculogenic mimicry test, wound 
healing assay, modified Boyden chamber assay를 시행하였다.  
결과: Bioinformatics analysis를 시행했을 때, EGFR, AKT2, MAPK1, VEGFA, 
HIF1AN이 miR-200c의 표적 유전자로 예측이 되었다. U251, T98G, A549, 
MDA-MB-468 세포 모두에서 miR-200c 를 과발현시키면 방사선민감성이 
향상되고, p-EGFR, p-PI3K, p-AKT, p-ERK 가 하향 조절되었다. 반대로 
miR-200c를 억제한 경우 방사선 유발 세포사멸이 감소하였고, p-EGFR, p-
PI3K, p-AKT, p-ERK 가 상향 조절되었다. 또한, 방사선조사 시 miR-200c
는 γH2AX 형성을 지속시키고 pDNA-PKc 발현을 하향 조절시켰다. miR-
200c 의 방사선 유발 세포사멸의 주된 방식이 세포고사 및 자가포식임을 
U251 과 A549 에서 확인하였다. 또한, miR-200c 는 EMT 기전과 관련된 
VEGF, HIF-1α, MMP2의 발현을 하향 조절하며, 세포의 침습, 이주 및 혈
관 형성을 억제함을 U251, A549 세포에서 확인하였다. 이러한 표현형의 
변화와 관련하여 E-cadherin 과 EphA2 는 하향 조절되고, N-cadherin 은 상
향 조절되었다. 정상 사람 섬유모세포와 아교세포를 대상으로 miR-200c
의 세포 독성은 발견되지 않았다. 
결론: miR-200c 는 인간암세포에서 방사선 유발 세포사멸 효과를 향상시
켰으며, 이는 생존촉진 (pro-surviving) EGFR 신호전달체계의 억제와 관련 
있음을 인산화된 신호전달물질의 면역블롯검사로 확인하였다. 또한 miR-
200c 는 암세포의 침습, 이주 및 혈관 형성 등 EMT 관련 기전을 억제하
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는 효과도 보였다. 이상의 결과를 바탕으로 볼 때 miR-200c 는 방사선치
료의 성적을 향상시킬 수 있는 효과적인 표적이 될 수 있을 것이다. 
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